BRIEF-FDA clears Biohaven's investigational new drug application for BHV-4157

Tue Jul 5, 2016 8:44am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 5 (Reuters) - Portage Biotech Inc :

* FDA clears Biohaven's investigational new drug application for BHV 4157 and portage to hold investor conference call to provide business update Source text for Eikon: Further company coverage: )